Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2008 / Cilt: 42 - Sayı: 1

Cutaneous manifestations in renal transplant recipients

Renal transplantasyon hastalarında gözlenen deri bulguları

Pages
18–21
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Warts were the most common manifestation in late post-transplantation period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: This study is designed to determine the prevalence and the clinical spectrum of skin diseases in renal transplant recipients (RTRs).
📊
Key Findings & Data:MATERIAL-METHOD: In this study RTRs who were referred to our department between 2005 and 2007 for dermatologic examination were evaluated.
💡
Conclusion & Impact:Warts were the most common manifestation in late post-transplantation period.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: This study is designed to determine the prevalence and the clinical spectrum of skin diseases in renal transplant recipients (RTRs). MATERIAL-METHOD: In this study RTRs who were referred to our department between 2005 and 2007 for dermatologic examination were evaluated. Dermatologic investigation included direct clinical observation and culture or histolopathological investigation when indicated. Patients were divided into three groups: group A, post-transplantation periods £1 year; group B, post-transplantation periods of 1-5 years; and group C, post-transplantation periods >5 years.RESULTS: In this study 88 (M=50, F=38) RTRs were evaluated. The mean age was 37 ± 12 years and the median interval since transplantation was 38.5 months (range=1 month-27 years). Over a 2-year period 298 cutaneous manifestations were identified. Ninety-five immunosuppressive (IS) drug-related manifestations were observed in 58 (%65.9) patients and the most common one was acneiform eruption (n=23). Forty (45.5%) patients developed cutaneous viral infections, consisting of verruca vulgaris (n=29), herpes zoster (n=9), herpes simplex (n=5), molluscum (n=2) and varicella (n=1) infections. Superficial fungal infections were observed in 35(39.2%) patients, most common lesions were dermatophytosis (n = 23) and pityriasis versicolor (n=17). Bacterial infections were observed in 14 (%16) patients, folliculitis was present in 12 of them. Premalignant and malignant lesions were identified in 12 (%13.6) patients, consisting of actinic keratoses (n=9), basal cell carcinoma (n=2), squamous cell carcinoma (n=1) and Kaposi's sarcoma (n=1). There were more premalignant and malignant lesions in patients receiving azathioprine (p=0.002). Cutaneous viral infections were more common in group C (p=0.023) and IS drug-related manifestations were more common in group A (p=0.003).CONCLUSION: Most common cutaneous manifestation among RTRs was IS drug-related and seen in early post-transplantation period. Warts were the most common manifestation in late post-transplantation period.

Özet

AMAÇ: Bu çalışmada merkezimizde renal transplantasyon (RT) yapılan hastalarda gözlenen deri bulgularının klinik özellikleri ve prevalansını belirlemek amaçlanmıştır. GEREÇ-YÖNTEM: Çalışmaya, RT nedeniyle izlenmekte olup 2005-2007 tarihleri arasında dermatolojiye konsülte edilen hastalar alındı. Tüm hastalara dermatolojik muayene yapıldı, gerektiğinde kültür alındı ve histopatolojik inceleme yapıldı. Hastalar; RT süresi ≤1 yıl, (grup A); RT süresi 1-5 yıl, (grup B); RT süresi >5 yıl, (grup C) olacak şekilde gruplandı. Sonuçlar ki-kare testi ile değerlendirildi. BULGULAR: Çalışmaya alınan 88 (E=50, K=38) hastanın yaş ortalaması 37±12 yıldı ve RT süresi ortancası 38.5 aydı (aralık: 1 ay-27 yıl). İki yıllık izlem süresince saptanan deri bulgusu sayısı 289 idi. İmmünsüpresif tedavi (İT) ilişkili deri bulguları 58 (%65.9) hastada, 95 lezyon olarak izlendi ve bunlar arasında en sık gözleneni akne (n=29) idi. Kırk (%45.5) hastada; verrü (n=34), herpes zoster (n=9), herpes simpleks (n=5), molluskum (n=2) ve variselladan (n=1) oluşan viral deri enfeksiyonu gözlendi. Yüzeyel fungal enfeksiyon 35 (%39.8) hastada, en sık dermatofitoz (n=23) ve pitriyazis versikolor (n=17) şeklindeydi. Bakteriyel enfeksiyon saptanan 14 (%15.9) hastanın, 12’sinde follikülit mevcuttu. Premalin ve malin lezyon izlenen 12 (%13.6) hastada; 9 aktinik keratoz, 3 bazal hücreli kanser, bir skuamöz hücreli kanser ve bir Kaposi sarkomu saptandı. Azatiyopürin kullanan hastalarda kullanmayanlara göre daha fazla premalin ve malin lezyon olduğu saptandı (p=0.002). Viral enfeksiyonların Grup C’ de (p=0.023), İT ilişkili deri bulgularının ise Grup A’ da (p=0.003) daha sık olduğu gözlendi. SONUÇ: RT hastalarında en sık gözlenen deri bulguları İT ilişkili deri bulgularıdır ve çoğunlukla erken dönemde ortaya çıkmaktadır. Verrüler ise geç dönemde gözlenmekte olan en sık deri bulgusudur.

🔖

Cite This Article

EVANS, E. S., ŞAHİN, S., DEMİRGÜNEŞ, F. E., YILMAZ, R., YASAVUL, Ü. (2022). Cutaneous manifestations in renal transplant recipients. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 42 - Sayı: 1, 18–21. https://ajindex.com/articles/622095

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-12
  2. Moloney FJ, Keane S, O'Kelly P, et al. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol 2005; 153: 574-8
  3. Lugo-Janer G, Sanchez JL, Santiago-Delphin E. Prevalence and clinical spectrum of skin diseases in kidney transplant recipients. J Am Acad Dermatol 1991; 24: 410-4
  4. Hampton T. Skin cancer’s ranks rise: immunosuppression to blame. JAMA 2005; 294: 1476-80
  5. Barba A, Tessari G, Boschiero L, et al. Renal transplantation and skin diseases: review of the literature and results of a 5-year follow- up of 285 patients. Nephron 1996; 73: 131-6
  6. Seckin D, Gulec TO, Demirag A, et al. Renal transplantation and skin diseases. Transplant Proc 1998; 30: 802-4
  7. McLelland J, Rees A, Williams G, et al. The incidence of immunosuppression- related skin disease in long-term transplant patients. Transplantation 1988; 46: 871-4
  8. Alper S, Kilinc I, Duman S, et al. Skin diseases in Turkish renal transplant recipients. Int J Dermatol 2005;44:939-41
  9. Vijayakumar R, Fernando E, Rajendran S, et al. Dermatological manifestations in renal transplant recipients. Transplant Proc 1998; 30: 3136
  10. Haim S, Friedman-Birnbaum R, Better OS, et al. Skin complications in immunosuppressed patients: follow-up of kidney recipients. Br J Dermatol 1973; 89: 169-73
  11. Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989;21;1:124-8
  12. Dyall-Smith D, Trowell H, Dyall-Smith ML. Benign human papillomavirus infection in renal transplant recipients. Int J Dermatol 1991;30:785-9
  13. Sontheimer RD, Bergstresser PR, Gailiunas P Jr, et al. Perturbation of epidermal Langerhans cells in immunosuppressed human renal allograft recipients. Transplantation 1984;37:168-74
  14. Harwood CA, Surentheran T, Sasieni P, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004;150: 949-57
  15. Formicone F, Fargnoli MC, Pisani F, et al. Cutaneous manifestations in Italian kidney transplant recipients. Transplant Proc 2005; 37: 2527-8
  16. Taşkapan O, Şener O, Yenicesu M, ve ark. Renal transplantlı olgularda deri bulgularının değerlendirilmesi. Diyaliz, Transplantasyon ve Yanık (Başkent Üniversitesi Tıp Bil